FierceBiotech

On Medtronic's tail, Axonics scores FDA nod for 15-year neurostim implant for incontinence

The race to treat a number of health conditions using neurostimulation technology is a marathon, not a sprint—but Medtronic and Axonics Modulation Technologies are still aiming for a photo finish. For ...
Finanznachrichten

Axonics Modulation Technologies, Inc.: Axonics Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of ...
FierceBiotech

Axonics executes $40M financing to commercialize neuromodulation device

Axonics has secured $40 million to support commercialization of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the end of a clinical trial ...
AOL

Medtronic ratchets up patent spat for device that aids in bladder, bowel control

Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
Yahoo Finance

Medtronic, Axonics Patent War Continues for Sacral Neuromodulation (Revised)

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

Medtronic Wins Neuromodulation Patent Dispute Against Axonics

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MD&M East

Medtronic Ups Its Game in Sacral Neuromodulation for Bowel and Bladder Control

Medtronic and Axonics have been going toe-to-toe in sacral neuromodulation — a fast-growing market that was monopolized by Medtronic until September 2019 — and the incumbent may have just gained the ...
pharmaphorum

NICE backs Axonics’ rechargeable device for overactive bladder

A device to treat urinary incontinence made by US biotech Axonics has been recommended for NHS use by NICE, which says it could save thousands of pounds in healthcare costs. The implantable Axonics ...
Orange County Business Journal

Device Maker Axonics Anticipates Sales Boost

Axonics Modulation Technologies Inc. Chief Executive Ray Cohen is nothing if not confident about becoming the market leader in his urology device category, despite renewed competition from medtech ...
Nasdaq

U.S. Patent Office Completes Review of Medtronic Patents, Rejects More Axonics Challenges

DUBLIN, Sept. 22, 2021 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark ...
Nasdaq

Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...